Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Cash from Financing Activities (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Cash from Financing Activities for 12 consecutive years, with $2.5 million as the latest value for Q1 2026.

  • For Q1 2026, Cash from Financing Activities fell 39.18% year-over-year to $2.5 million; the TTM value through Mar 2026 reached $486.6 million, up 99.81%, while the annual FY2025 figure was $488.2 million, 92.3% up from the prior year.
  • Cash from Financing Activities hit $2.5 million in Q1 2026 for Wave Life Sciences, down from $439.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $439.7 million in Q4 2025 and bottomed at $17000.0 in Q3 2022.
  • Average Cash from Financing Activities over 5 years is $55.6 million, with a median of $11.7 million recorded in 2025.
  • Year-over-year, Cash from Financing Activities crashed 99.84% in 2022 and then surged 170740.0% in 2023.
  • Wave Life Sciences' Cash from Financing Activities stood at $55000.0 in 2022, then soared by 170740.0% to $94.0 million in 2023, then tumbled by 62.77% to $35.0 million in 2024, then surged by 1156.95% to $439.7 million in 2025, then crashed by 99.43% to $2.5 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $2.5 million, $439.7 million, and $32.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.